Basel Medical Group Ltd Ordinary Shares·Healthcare
Singapore, March 24, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) today announced that it has received notification from Nasdaq that based on the Company's amended annual report on Form 20-F for the fiscal year of 2025, which was filed with the SEC on March 13, 2026, Nasdaq Staff has now determined that the Company has complied with the periodic filing requirement for The Nasdaq Stock Market under Listing Rule 5250(c)(1) (the “Periodic Filing Rule”). Accordingly, the prior deficiency relating to the Periodic Filing Rule has now been resolved.
Singapore, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”), today announced that it has received notification from Nasdaq that based on the closing bid price of the Company's shares for the last 30 consecutive business days, the Company no longer meets the requirements under Nasdaq's Listing Rules (the “Rules”) for listed securities to maintain a minimum bid price of $1 per share.
Basel Medical Group Ltd (NASDAQ: BMGL - Get Free Report)'s share price was up 1.5% during trading on Monday. The company traded as high as $0.6703 and last traded at $0.6432. Approximately 41,958 shares changed hands during mid-day trading, a decline of 40% from the average daily volume of 70,156 shares. The stock had previously
